title: NCCN Task Force report: gastrointestinal stromal tumor (GIST).
authors.affiliation: Dana-Farber/Partners CancerCare, Brigham & Women's Hospital, 44 Binney Street, Boston, MA 02115, USA. demetri@macmailgw.dfci.harvard.edu
authors.forename: George
authors.initials: G
authors.lastname: Demetri
authors.forename: Ronald P
authors.initials: RP
authors.lastname: DeMatteo
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D018450:Disease Progression; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D046152:Gastrointestinal Stromal Tumors / Q000175:diagnosis / Q000556:secondary / Q000628:therapy*; D006801:Humans; D000068877:Imatinib Mesylate; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000601:surgery; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate